Mepro Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 36 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), MINSA (CR) and DAV (Vietnam). Its GMP standing is certified by EMA, CDSCO (India) and MHRA (UK). Customs aggregates show $30.5M of exports covering 1,294 molecules to 39 destinations in 2025.
| Site | FDA FEI |
|---|---|
| SURENDRANAGAR, India | Not on file |
| Vadodra, India | Not on file |
| Wadhwan City Surendra Nagar, India | Not on file |
| surat 394 230surat, India | Not on file |
| od samlaya roadvadodaravado dara 391 520, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 28 | None |
| MINSA (CR) | 7 | None |
| DAV (Vietnam) | 1 | None |
| EMA | None | 5 |
| CDSCO (India) | None | 4 |
| MHRA (UK) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $5.5M | 24 |
| 2025 | Not reported | $30.5M | 39 |
| 2024 | Not reported | $27.4M | 43 |
| 2023 | Not reported | $22.7M | 35 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Mepro Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.